60 years of growth and innovation
Mr. H.N. Walsdorf, a pharmacist and a visionary, founded Mission Pharmacal. He set the stage for pharmaceutical breakthroughs with the philosophy that most existing pharmaceutical formulations had the potential to be more therapeutically effective. He often said, "A pharmaceutical product is no better than the purity and quality of the raw materials that go in to its production."
Mission's growth as a pharmaceutical company has been fueled by its commitment to research and providing the highest quality products. Mission is dedicated to ensuring that its products are available in the best therapeutic forms. Ever expanding, state-of-the-art technologies are the tools for Mission's dedicated and highly-skilled employees. Mission is prepared to continue its growth today, tomorrow, and in to the next century.
Mission's growth as a pharmaceutical company and its future success stories can be attributed to preparedness, anticipating the changing health needs of the world, and a commitment to research and development. Mission provides the best quality product in the best therapeutic form, by utilizing the science-based initiative to improve consumers' enjoyment of life.
Continuity and performance
Continuity of the Walsdorf family contributes to the strength of Mission. After more than 50 years of excellence, this vibrant, Texas-based company is still privately held. The founding family is in its third generation. Neill B. Walsdorf, Jr., President, carries on the traditions of quality and value established by his grandfather and carried on by his father.
The family atmosphere extends to Mission's employees, making Mission unique in an industry filled with large corporations. Several generations of families are represented in Mission's work force. To these dedicated families, Mission is a life's work.
Mission has experienced solid growth and profitability in every one of its 60-plus years. Today, Mission enjoys setting the gold standards in the areas of therapeutic drugs, diagnostic testing, and dietary supplements. Being the leader in these fields has extended to many foreign markets, including Asia, South America, Australia, and Canada. The Mission philosophy is still the catalyst for the company's world-wide respect.
Looking Toward the Future
With today's advances in healthcare and accompanying longer life spans, it is incumbent on Mission Pharmacal to have a long-term vision. Mission's future holds the promise of important advances that will improve our understanding of osteoporosis and kidney stone disease, as well as other disease states, and will lead to more effective therapeutics. Pharmacological treatment will not only aim at functional intervention, but newer diagnostic techniques will permit earlier treatment and prevention.
Because Mission Pharmacal anticipates an expanding world market, we are widening our horizons to include international corporate partnerships. To this end, we have developed marketing agreements in Asia, Europe, and South America for Mission Pharmacal products, thus bringing our vision of therapeutic innovations for a better quality of life to the international arena.
Mission Pharmacal embraces the future with much enthusiasm and dedication, as it continues to develop therapeutics that will benefit people across the globe.
More than 500,000 babies are born too soon each year. Some are so small they struggle to survive. This year, Mission Pharmacal is joining forces with the March of Dimes* as a National Corporate Sponsor to help raise awareness about the growing crisis of premature birth. To learn more and help us fight prematurity, click on the links below. For more than 60 years, Mission Pharmacal has been committed to providing products for healthy women and healthy babies.
Think twice about your choices for treating bacterial vaginosis.
Prescription iron therapies are not interchangeable! Ferralet 90 contains carbonyl iron and a unique, gentle formulation that transforms a patient's experience on iron therapy.
